Kelly Shi
Stock Analyst at Jefferies
(2.00)
# 3,088
Out of 4,893 analysts
31
Total ratings
41.38%
Success rate
-4.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $10.96 | +155.47% | 1 | Jul 7, 2025 | |
| INSM Insmed | Initiates: Buy | $105 | $97.86 | +7.30% | 1 | May 13, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $24.86 | +76.99% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $4.71 | +218.81% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $24.18 | +115.05% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.40 | +159.50% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $14.30 | +32.87% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $175.23 | +11.85% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $2.05 | +924.39% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $9.62 | +284.62% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $4.68 | +28.21% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $48.26 | -4.68% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $68.73 | +17.86% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.53 | +62.56% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.74 | +1,968.97% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $48.71 | -67.15% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $44.03 | -9.15% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.12 | +290.63% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.82 | +184.19% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.75 | +3,487.09% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $16.07 | +223.58% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.51 | +1,688.08% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.91 | +1,627.75% | 1 | Mar 8, 2021 |
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $10.96
Upside: +155.47%
Insmed
May 13, 2025
Initiates: Buy
Price Target: $105
Current: $97.86
Upside: +7.30%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $24.86
Upside: +76.99%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.71
Upside: +218.81%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $24.18
Upside: +115.05%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.40
Upside: +159.50%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $14.30
Upside: +32.87%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $175.23
Upside: +11.85%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $2.05
Upside: +924.39%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $9.62
Upside: +284.62%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $4.68
Upside: +28.21%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $48.26
Upside: -4.68%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $68.73
Upside: +17.86%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $21.53
Upside: +62.56%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.74
Upside: +1,968.97%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $48.71
Upside: -67.15%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $44.03
Upside: -9.15%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $5.12
Upside: +290.63%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.82
Upside: +184.19%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.75
Upside: +3,487.09%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $16.07
Upside: +223.58%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.51
Upside: +1,688.08%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.91
Upside: +1,627.75%